Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Occidental Petroleum
OXY
5
Louisiana-Pacific
LPX
CN Stock MarketDetailed Quotes
300404 Boji Medical Technology
- 8.28
- -0.17-2.01%
Market Closed May 9 15:00 CST
3.17BMarket Cap197.14P/E (TTM)
8.47High8.25Low92.67KlotVolume8.45Open8.45Pre Close77.08MTurnover3.33%Turnover Ratio110.40P/E (Static)383.17MShares11.5452wk High3.22P/B2.30BFloat Cap6.8452wk Low10.14Limit Up278.06MShs Float42.36Historical High6.76Limit Down2.60%Amplitude3.52Historical Low0.01Dividend TTM8.32Avg Price55.48KlotAsk0.12%Div YieldTTM100Lot Size35.77KlotBid
About Boji Medical Technology Company
The company was founded in 2002 and listed on the Shenzhen GEM in 2015. The company is one of CRO listed companies whose main business is clinical trials. Clinical research is one of the company's core businesses. The scope of business includes registration research and post-marketing evaluation of drugs and medical devices. It is particularly good at clinical research on innovative drugs and innovative medical devices. The company is a professional CRO service provider, mainly providing a full-process “one-stop” CRO service for domestic and foreign pharmaceutical companies and other research institutions for the development and production of new drugs and medical devices. Corporate honors: Top 20 Chinese Pharmaceutical Outsourcing Companies; Guangzhou Famous Trademark; Chinese Pharmaceutical Industry Brand Service Provider; Little Tech Giant Enterprise;; “2023 Top 10 Most Competitive Chinese Pharmaceutical Service Companies”; “2022 China's Top 20 Pharmaceutical CRO Companies”; “2022 China's Top 50 Pharmaceutical R&D Companies”; “2024 China's Top 20 Pharmaceutical CRO Companies (ranked 8th)”; “Top 50 Chinese Pharmaceutical R&D Companies in 2024”; “Top 50 Chinese Pharmaceutical Research and Development Companies”; “Top 100 Chinese Life Science Service Enterprises” Outstanding Achievement Award, etc.
Company Profile
Short Name-A博济医药
Symbol-A300404
Company NameBoji Medical & Technological Co. Ltd.
Listing DateApr 24, 2015
Issue Price12.87
Shares Offered16.67M share(s)
FoundedSep 29, 2002
Legal Representativetingchun wang
General Managertingchun wang
Secretaryfangqun wei
Accounting FirmGuangdong Sinong Accounting Firm (Special General Partnership)
Securities Representativeshaohua chen
Legal CounselBeijing Kangda (Guangzhou) Law Firm
Employees482
Phone020-35647628
Office Address7th Floor, Building A, Wankeyun Plaza, No. 1933 Huaguan Road, Tianhe District, Guangzhou
Zip Code510640
Registered AddressBuilding 62 (2, 3, 4, 5), Nanxiang 1st Road, Science City, Huangpu District, Guangzhou, Guangdong
Fax020-38473053
Emailboard@gzboji.com
Websitehttp://www.gzboji.com
Business License440106000113076
BusinessMedical research and experimental development; technical services, technology development, technical consulting, technology exchange, technology transfer, technology promotion; information technology consulting services; information consulting services (excluding licensing information consulting services); technology intermediary services; household chemicals sales; machinery and equipment sales; office equipment sales; disinfectant sales (excluding hazardous chemicals); Class I medical device leasing; Class II medical device leasing; machinery and equipment leasing; land use rights leasing; non-residential real estate leasing; leasing services (excluding licensing services); housing leasing; medical equipment; office equipment Leasing services; Computer and communication equipment leasing; Drug testing equipment manufacturing; Specialty chemical products manufacturing (excluding hazardous chemicals); Household chemicals manufacturing; Medical packaging materials manufacturing; Conference and exhibition services; Licensing projects: import and export of technology; Medical services; Medical device Internet information services; Pharmaceutical production; Drug contract production; Pharmaceutical wholesale; Production of protective equipment for medical personnel (Class II medical devices)
Company Executives
- Name
- Position
- Salary
- tingchun wang
- Chairman, Directors, General Manager, Nomination Committee Members, Chairman of the Strategy Committee
- 391.00K
- kejian zhang
- Directors, Member of the Remuneration and Assessment Committee
- 84.00K
- quan zhu
- Directors, Deputy General Manager, Strategy Committee Member
- 1.48M
- bo tan
- Directors, Strategy Committee Member
- 1.02M
- huayi li
- Independent Directors, Chairman of the Audit Committee, Member of the Remuneration and Assessment Committee
- 84.00K
- kang xie
- Independent Directors, Audit Committee Member, Chairman of the Nomination Committee
- 84.00K
- qing chen
- Independent Directors, Nomination Committee Members, Chairman of the Remuneration and Assessment Committee, Audit Committee Member
- 84.00K
- fangqun wei
- Board Secretary, Deputy General Manager
- 542.00K
- shaohua chen
- Securities Affairs Representative
- --
- jingchun liu
- Chairman of the Supervisory Board, Employee Supervisors
- 444.90K
- peidan xian
- Auditors
- 179.50K
- fang wang
- Auditors
- 297.30K
- lian zuo
- Deputy General Manager
- 1.20M
- shaobo wen
- Deputy General Manager
- 1.12M
- xiuqing ou
- Deputy General Manager, Chief Financial Officer
- 493.00K
- lijuan zhang
- Head of Internal Audit
- --
Market Insights
Warren Buffett Portfolio Warren Buffett Portfolio
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.
Unlock Now
Discussing
Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve
Buffettttttt
May 3 21:00
Berkshire's 2025 Annual Shareholders Meeting